{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:43:58Z","timestamp":1790970238363,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2003,5,25]],"date-time":"2003-05-25T00:00:00Z","timestamp":1053820800000},"content-version":"vor","delay-in-days":1027,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1006\/nbdi.2000.0319","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T15:46:43Z","timestamp":1032364003000},"page":"240-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":342,"title":["Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease"],"prefix":"10.1006","volume":"7","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valina L.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/nbdi.2000.0319_RF1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/hmg\/8.4.567","article-title":"A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease","volume":"8","author":"Abbas","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1006\/nbdi.2000.0319_RF2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"10.1006\/nbdi.2000.0319_RF3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0304-3940(99)00311-0","article-title":"Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores","volume":"266","author":"Bayer","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1006\/nbdi.2000.0319_RF4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.1994.tb21791.x","article-title":"Peroxynitrite versus hydroxyl radical: The role of nitric oxide in superoxide-dependent cerebral injury","volume":"738","author":"Beckman","year":"1994","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1006\/nbdi.2000.0319_RF5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2307\/3576299","article-title":"Poly(ADP-ribose) in the cellular response to DNA damage","volume":"101","author":"Berger","year":"1985","journal-title":"Radiat. Res."},{"key":"10.1006\/nbdi.2000.0319_RF6","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1212\/WNL.42.10.1894","article-title":"Parkinson's disease in twins studied with 18F-dopa and positron emission tomography","volume":"42","author":"Burn","year":"1992","journal-title":"Neurology"},{"key":"10.1006\/nbdi.2000.0319_RF7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1212\/WNL.50.2.513","article-title":"Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease","volume":"50","author":"Chan","year":"1998","journal-title":"Neurology"},{"key":"10.1006\/nbdi.2000.0319_RF8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-2236(97)01213-7","article-title":"The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease","volume":"21","author":"Clayton","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1006\/nbdi.2000.0319_RF9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1006\/nbdi.2000.0319_RF10","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi991447r","article-title":"Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid","volume":"39","author":"Conway","year":"2000","journal-title":"Biochemistry"},{"key":"10.1006\/nbdi.2000.0319_RF11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2000.0319_RF12","first-page":"264","article-title":"Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1\/6 mice","volume":"729","author":"Cosi","year":"1996","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0319_RF13","first-page":"57","article-title":"The role of peroxynitrite in nitric oxide-mediated toxicity","volume":"196","author":"Crow","year":"1995","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1006\/nbdi.2000.0319_RF14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80629-7","article-title":"New animal models for Parkinson's disease","volume":"101","author":"Dawson","year":"2000","journal-title":"Cell"},{"key":"10.1006\/nbdi.2000.0319_RF15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0968-0004(94)90280-1","article-title":"Poly(ADP-ribose) polymerase: A molecular nick-sensor","volume":"19","author":"de Murcia","year":"1994","journal-title":"Trends Biochem. Sci."},{"key":"10.1006\/nbdi.2000.0319_RF16","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1046\/j.1471-4159.2000.0742213.x","article-title":"Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo [In Process Citation]","volume":"74","author":"Dehmer","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2000.0319_RF17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(86)92471-2","article-title":"Lipid peroxidation as cause of nigral cell death in Parkinson's disease [Letter]","volume":"2","author":"Dexter","year":"1986","journal-title":"Lancet"},{"key":"10.1006\/nbdi.2000.0319_RF18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1471-4159.1990.tb08814.x","article-title":"Decreased ferritin levels in brain in Parkinson's disease","volume":"55","author":"Dexter","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2000.0319_RF19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","article-title":"Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2000.0319_RF20","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1002\/ana.410320716","article-title":"Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group","volume":"32","author":"Dexter","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF21","doi-asserted-by":"crossref","first-page":"A32","DOI":"10.1038\/399a032","article-title":"Prospects for new restorative and neuroprotective treatments in Parkinson's disease","volume":"399","author":"Dunnett","year":"1999","journal-title":"Nature"},{"key":"10.1006\/nbdi.2000.0319_RF22","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1097\/00001756-199812010-00029","article-title":"Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases","volume":"9","author":"El-Agnaf","year":"1998","journal-title":"Neuroreport"},{"key":"10.1006\/nbdi.2000.0319_RF23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-5793(98)01419-7","article-title":"Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease","volume":"440","author":"El-Agnaf","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1006\/nbdi.2000.0319_RF24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/8820","article-title":"Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions","volume":"22","author":"Engelender","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1006\/nbdi.2000.0319_RF25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/hmg\/8.1.81","article-title":"A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor","volume":"8","author":"Farrer","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1006\/nbdi.2000.0319_RF26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"A Drosophila model of Parkinson's disease [see Comments]","volume":"404","author":"Feany","year":"2000","journal-title":"Nature"},{"key":"10.1006\/nbdi.2000.0319_RF27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/1531-8249(200005)47:5<632::AID-ANA11>3.0.CO;2-N","article-title":"Alpha-synuclein and Parkinson's disease: Selective neurodegenerative effect of alpha-synuclein fragment on dopaminergic neurons in vitro and in vivo [In Process Citation]","volume":"47","author":"Forloni","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0079-6123(08)61770-7","article-title":"Astrocytes and Parkinson's disease","volume":"94","author":"Forno","year":"1992","journal-title":"Prog. Brain Res."},{"key":"10.1006\/nbdi.2000.0319_RF29","first-page":"600","article-title":"Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations","volume":"60","author":"Forno","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF30","first-page":"809","article-title":"Filaments of Lewy bodies contain insoluble cytoskeletal elements","volume":"140","author":"Galloway","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1006\/nbdi.2000.0319_RF31","first-page":"313","article-title":"Pathobiology of the Lewy body","volume":"80","author":"Galvin","year":"1999","journal-title":"Adv. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF32","doi-asserted-by":"crossref","first-page":"13450","DOI":"10.1073\/pnas.96.23.13450","article-title":"Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein","volume":"96","author":"Galvin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2000.0319_RF33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ng0398-262","article-title":"A susceptibility locus for Parkinson's disease maps to chromosome 2p13","volume":"18","author":"Gasser","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1006\/nbdi.2000.0319_RF34","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1074\/jbc.274.12.7619","article-title":"Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro","volume":"274","author":"Giasson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1006\/nbdi.2000.0319_RF35","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s004010051135","article-title":"alpha-Synuclein immunoreactivity in dementia with Lewy bodies: Morphological staging and comparison with ubiquitin immunostaining [In Process Citation]","volume":"99","author":"Gomez-Tortosa","year":"2000","journal-title":"Acta Neuropathol. (Berlin)"},{"key":"10.1006\/nbdi.2000.0319_RF36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00005072-199804000-00006","article-title":"Protein nitration in Parkinson's disease","volume":"57","author":"Good","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF37","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/70918","article-title":"NOS knockouts and neuroprotection [news; comment]","volume":"5","author":"Grunewald","year":"1999","journal-title":"Nat. Med."},{"key":"10.1006\/nbdi.2000.0319_RF38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1212\/WNL.54.2.504","article-title":"A kindred with Parkinson's disease not showing genetic linkage to established loci","volume":"54","author":"Gwinn-Hardy","year":"2000","journal-title":"Neurology"},{"key":"10.1006\/nbdi.2000.0319_RF39","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nm0996-1017","article-title":"Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons [see Comments]","volume":"2","author":"Hantraye","year":"1996","journal-title":"Nat. Med."},{"key":"10.1006\/nbdi.2000.0319_RF40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(99)00465-6","article-title":"The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease","volume":"270","author":"Harhangi","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1006\/nbdi.2000.0319_RF41","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0006-291X(90)90498-C","article-title":"1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles","volume":"170","author":"Hasegawa","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/nbdi.2000.0319_RF42","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00001756-199903170-00011","article-title":"Oxidative stress induces amyloid-like aggregate formation of NACP\/alpha-synuclein in vitro","volume":"10","author":"Hashimoto","year":"1999","journal-title":"Neuroreport"},{"key":"10.1006\/nbdi.2000.0319_RF43","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1750-3639.1999.tb00552.x","article-title":"Alpha-synuclein in Lewy body disease and Alzheimer's disease","volume":"9","author":"Hashimoto","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1006\/nbdi.2000.0319_RF44","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/ana.410440612","article-title":"Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: Evidence for variable homozygous deletions in the Parkin gene in affected individuals","volume":"44","author":"Hattori","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF45","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1006\/bbrc.1998.9134","article-title":"Point mutations (Thr240Arg and Gln311Stop) [correction of Thr240Arg and Ala311Stop] in the Parkin gene","volume":"249","author":"Hattori","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/nbdi.2000.0319_RF46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/311467a0","article-title":"Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors","volume":"311","author":"Heikkila","year":"1984","journal-title":"Nature"},{"key":"10.1006\/nbdi.2000.0319_RF47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.410360209","article-title":"Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits","volume":"36","author":"Holthoff","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00005072-199804000-00005","article-title":"Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity","volume":"57","author":"Irizarry","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1212\/WNL.47.1.160","article-title":"Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism","volume":"47","author":"Ishikawa","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/nbdi.2000.0319_RF50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1098-2396(19991215)34:4<305::AID-SYN6>3.0.CO;2-#","article-title":"Methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice","volume":"34","author":"Itzhak","year":"1999","journal-title":"Synapse"},{"key":"10.1006\/nbdi.2000.0319_RF51","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2000.0319_RF52","first-page":"267","article-title":"Iron and ferritin in substantia nigra in Parkinson's disease","volume":"60","author":"Jellinger","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF53","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1021\/bi972776r","article-title":"Regulation of phospholipase D2: Selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins","volume":"37","author":"Jenco","year":"1998","journal-title":"Biochemistry"},{"key":"10.1006\/nbdi.2000.0319_RF54","first-page":"57","article-title":"Oxidative stress in Parkinson's disease and other neurodegenerative disorders","volume":"44","author":"Jenner","year":"1996","journal-title":"Pathol. Biol. (Paris)"},{"key":"10.1006\/nbdi.2000.0319_RF55","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1002\/ana.410440712","article-title":"Understanding cell death in Parkinson's disease","volume":"44","author":"Jenner","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF56","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.274.36.25481","article-title":"alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356","volume":"274","author":"Jensen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1006\/nbdi.2000.0319_RF57","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M000099200","article-title":"Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments","author":"Jensen","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1006\/nbdi.2000.0319_RF58","doi-asserted-by":"crossref","first-page":"26292","DOI":"10.1074\/jbc.273.41.26292","article-title":"Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation","volume":"273","author":"Jensen","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1006\/nbdi.2000.0319_RF59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/nlme.1997.3795","article-title":"Synelfin regulation during the critical period for song learning in normal and isolated juvenile zebra finches","volume":"68","author":"Jin","year":"1997","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1006\/nbdi.2000.0319_RF60","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.286.5438.309","article-title":"The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase [see comments]","volume":"286","author":"Joazeiro","year":"1999","journal-title":"Science"},{"key":"10.1006\/nbdi.2000.0319_RF61","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism [see Comments]","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1006\/nbdi.2000.0319_RF62","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00001756-199902250-00035","article-title":"Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity","volume":"10","author":"Klevenyi","year":"1999","journal-title":"Neuroreport"},{"key":"10.1006\/nbdi.2000.0319_RF63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.20-01-00001.2000","article-title":"Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"20","author":"Klivenyi","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.2000.0319_RF64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/nbdi.1998.0191","article-title":"Manganese superoxide dismutase overexpression attenuates MPTP toxicity","volume":"5","author":"Klivenyi","year":"1998","journal-title":"Neurobiol. Dis."},{"key":"10.1006\/nbdi.2000.0319_RF65","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.ne.11.030188.000501","article-title":"MPTP toxicity: implications for research in Parkinson's disease","volume":"11","author":"Kopin","year":"1988","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1006\/nbdi.2000.0319_RF66","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001756-200001170-00041","article-title":"MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons","volume":"11","author":"Kowall","year":"2000","journal-title":"Neuroreport"},{"key":"10.1006\/nbdi.2000.0319_RF67","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease [Letter]","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1006\/nbdi.2000.0319_RF68","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/nbdi.2000.0319_RF69","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","article-title":"Parkinson's disease. Second of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/nbdi.2000.0319_RF70","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1212\/WNL.47.6_Suppl_3.153S","article-title":"The etiology of Parkinson's disease with emphasis on the MPTP story","volume":"47","author":"Langston","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/nbdi.2000.0319_RF71","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01076101","article-title":"Molecular and biochemical features of poly (ADP-ribose) metabolism","volume":"122","author":"Lautier","year":"1993","journal-title":"Mol. Cell. Biochem."},{"key":"10.1006\/nbdi.2000.0319_RF73","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s004390050845","article-title":"Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson's disease","volume":"103","author":"Leroy","year":"1998","journal-title":"Hum. Genet."},{"key":"10.1006\/nbdi.2000.0319_RF74","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease [see Comments]","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1006\/nbdi.2000.0319_RF75","doi-asserted-by":"crossref","first-page":"11364","DOI":"10.1073\/pnas.96.20.11364","article-title":"RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination","volume":"96","author":"Lorick","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2000.0319_RF76","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/path.1711610210","article-title":"Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases","volume":"161","author":"Lowe","year":"1990","journal-title":"J. Pathol."},{"key":"10.1006\/nbdi.2000.0319_RF77","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0140-6736(05)60746-5","volume":"352","author":"Lucking","year":"1998","journal-title":"Lancet"},{"key":"10.1006\/nbdi.2000.0319_RF78","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson's disease and mutations in the parkin gene","volume":"342","author":"Lucking","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/nbdi.2000.0319_RF79","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1073\/pnas.96.10.5774","article-title":"Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism","volume":"96","author":"Mandir","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2000.0319_RF80","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/WNL.53.8.1858","article-title":"Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease","volume":"53","author":"Maraganore","year":"1999","journal-title":"Neurology"},{"key":"10.1006\/nbdi.2000.0319_RF81","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1212\/WNL.46.1.231","article-title":"[123I] beta-CIT\/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease","volume":"46","author":"Marek","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/nbdi.2000.0319_RF82","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.1006\/nbdi.2000.0319_RF83","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1006\/exnr.1996.6406","article-title":"S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity","volume":"143","author":"Matthews","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF84","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0753-3322(99)80075-4","article-title":"Genetics of Parkinson's disease","volume":"53","author":"Mizuno","year":"1999","journal-title":"Biomed. Pharmacother."},{"key":"10.1006\/nbdi.2000.0319_RF85","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0925-4439(95)00038-6","article-title":"Role of mitochondria in the etiology and pathogenesis of Parkinson's disease","volume":"1271","author":"Mizuno","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1006\/nbdi.2000.0319_RF86","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0968-0004(99)01381-X","article-title":"A novel transactivation domain in parkin [Letter]","volume":"24","author":"Morett","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1006\/nbdi.2000.0319_RF87","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.51.3.890","article-title":"Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q [see Comments]","volume":"51","author":"Mori","year":"1998","journal-title":"Neurology"},{"key":"10.1006\/nbdi.2000.0319_RF88","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1523\/JNEUROSCI.19-14-05782.1999","article-title":"alpha-Synuclein shares physical and functional homology with 14-3-3 proteins","volume":"19","author":"Ostrerova","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.2000.0319_RF89","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/WNL.52.3.651","article-title":"Mutated alpha-synuclein gene in two Greek kindreds with familial PD: Incomplete penetrance?","volume":"52","author":"Papadimitriou","year":"1999","journal-title":"Neurology"},{"key":"10.1006\/nbdi.2000.0319_RF90","unstructured":"Parkinson, J. 1817, An essay on the shaking palsy. Sherwood, Neely, and Jones."},{"key":"10.1006\/nbdi.2000.0319_RF91","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1212\/WNL.51.6.1757","article-title":"Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease","volume":"51","author":"Parsian","year":"1998","journal-title":"Neurology"},{"key":"10.1006\/nbdi.2000.0319_RF92","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.410410213","article-title":"Dopaminergic function in familial Parkinson's disease: A clinical and 18F-dopa positron emission tomography study","volume":"41","author":"Piccini","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF93","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00005072-199305000-00001","article-title":"Pathology and biology of the Lewy body","volume":"52","author":"Pollanen","year":"1993","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF94","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","article-title":"Mapping of a gene for Parkinson's disease to chromosome 4q21-q23 [see Comments]","volume":"274","author":"Polymeropoulos","year":"1996","journal-title":"Science"},{"key":"10.1006\/nbdi.2000.0319_RF95","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [see Comments]","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1006\/nbdi.2000.0319_RF96","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1073\/pnas.93.10.4565","article-title":"Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity","volume":"93","author":"Przedborski","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2000.0319_RF97","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1523\/JNEUROSCI.12-05-01658.1992","article-title":"Transgenic mice with increased Cu\/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity","volume":"12","author":"Przedborski","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.2000.0319_RF98","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-6147(00)01470-X","article-title":"Reply: A new look at the pathogenesis of Parkinson's disease","volume":"21","author":"Przedborski","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1006\/nbdi.2000.0319_RF99","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/12647","article-title":"Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice [see Comments]","volume":"23","author":"Saigoh","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1006\/nbdi.2000.0319_RF100","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ana.410320503","article-title":"The identification of presymptomatic parkinsonism: Clinical and [18F]dopa positron emission tomography studies in an Irish kindred","volume":"32","author":"Sawle","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF101","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1002\/ana.410440714","article-title":"Mitochondria in the etiology and pathogenesis of Parkinson's disease","volume":"44","author":"Schapira","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF102","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00005072-198807000-00006","article-title":"Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain","volume":"47","author":"Schneider","year":"1988","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF103","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1046\/j.1471-4159.1995.64020936.x","article-title":"Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice","volume":"64","author":"Schulz","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2000.0319_RF104","first-page":"1500","article-title":"Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients","volume":"39","author":"Seibyl","year":"1998","journal-title":"J. Nucl. Med."},{"key":"10.1006\/nbdi.2000.0319_RF105","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z","article-title":"Immunohistochemical and subcellular localization of Parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients","volume":"45","author":"Shimura","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF106","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia [see Comments]","volume":"36","author":"Sian","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF107","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0140-6736(87)90722-7","article-title":"Free radicals, lipid peroxidation, and Parkinson's disease [Letter]","volume":"1","author":"Smith","year":"1987","journal-title":"Lancet"},{"key":"10.1006\/nbdi.2000.0319_RF108","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1750-3639.1998.tb00162.x","article-title":"Frontotemporal dementia and Parkinsonism linked to chromosome 17: A new group of tauopathies","volume":"8","author":"Spillantini","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1006\/nbdi.2000.0319_RF109","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2000.0319_RF110","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies [Letter]","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1006\/nbdi.2000.0319_RF111","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(98)01193-6","article-title":"Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion","volume":"19","author":"Szabo","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1006\/nbdi.2000.0319_RF112","first-page":"367","article-title":"Abnormal accumulation of NACP\/alpha-synuclein in neurodegenerative disorders","volume":"152","author":"Takeda","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1006\/nbdi.2000.0319_RF113","first-page":"73","article-title":"Processing of MPTP by monoamine oxidases: Implications for molecular toxicology","volume":"23","author":"Trevor","year":"1987","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1006\/nbdi.2000.0319_RF114","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/sj.cdd.4400432","article-title":"Fatal attractions: Abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia [see Comments]","volume":"5","author":"Trojanowski","year":"1998","journal-title":"Cell Death Differ."},{"key":"10.1006\/nbdi.2000.0319_RF115","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"Ueda","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2000.0319_RF116","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/hmg\/7.4.751","article-title":"Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD)","volume":"7","author":"Vaughan","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1006\/nbdi.2000.0319_RF117","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/1531-8249(200004)47:4<521::AID-ANA18>3.0.CO;2-B","article-title":"Synphilin-1 is present in Lewy bodies in Parkinson's disease","volume":"47","author":"Wakabayashi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF118","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s004010050918","article-title":"Accumulation of alpha-synuclein\/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy","volume":"96","author":"Wakabayashi","year":"1998","journal-title":"Acta Neuropathol. (Berlin)"},{"key":"10.1006\/nbdi.2000.0319_RF119","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/archneur.55.12.1521","article-title":"The G209A mutation in the alpha-synuclein gene is not detected in familial cases of Parkinson disease in non-Greek and\/or Italian populations","volume":"55","author":"Wang","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1006\/nbdi.2000.0319_RF120","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.2530630","article-title":"The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase","volume":"246","author":"Wilkinson","year":"1989","journal-title":"Science"},{"key":"10.1006\/nbdi.2000.0319_RF121","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ana.410410218","article-title":"Maternal inheritance in Parkinson's disease","volume":"41","author":"Wooten","year":"1997","journal-title":"Ann. Neurol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999610090319X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999610090319X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:57:58Z","timestamp":1760849878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999610090319X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S096999610090319X"],"URL":"https:\/\/doi.org\/10.1006\/nbdi.2000.0319","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/nbdi.2000.0319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}